Prevalence of Joint Disease in Patients with Psoriasis: Implications for Therapy

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.4, Iss.7, 2003-01, pp. : 441-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab Therapy for Psoriasis in Patients with Inadequate Responses to Etanercept

By Kramer Jesse M.

American Journal of Clinical Dermatology, Vol. 10, Iss. 2, 2009-01 ,pp. : 134-140

Adis International

Access to resources Recommend Favorite

Prevalence of Antigliadin Antibodies in Patients with Psoriasis is Not Elevated Compared with Controls

By Kia Kevin F.

American Journal of Clinical Dermatology, Vol. 8, Iss. 5, 2007-01 ,pp. : 301-305

Adis International

Access to resources Recommend Favorite

Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy

By Enns Gregory M. Cowan Tina M.

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-05 ,pp. : 50-50

MDPI

Access to resources Recommend Favorite

Ultrasound for Early Detection of Joint Disease in Patients with Hemophilic Arthropathy

By Di Minno Matteo Nicola Dario Pasta Gianluigi Airaldi Sonia Zaottini Federico Storino Antonio Cimino Ernesto Martinoli Carlo

Journal of Clinical Medicine, Vol. 6, Iss. 8, 2017-07 ,pp. : 77-77

MDPI

Access to resources Recommend Favorite

Cognitive Behavioral Therapy in Patients With Sickle Cell Disease

Creative Nursing, Vol. 21, Iss. 1, 2015-02 ,pp. : 38-46

Springer Publishing Company

Access to resources Recommend Favorite